In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Comparative Prognostic Value of the Cumulative Intracranial Tumor Volume (CITV) and Score Index for Radiosurgery (SIR) in Brain Metastasis

    Final Number:
    339

    Authors:
    Brian R Hirshman MD, MS; Bayard Wilson BA; Proudfoot A James; Takao Koiso; Osamu Nagano; Bob S. Carter MD, PhD; Toru Serizawa; Masaaki Yamamoto MD; Clark C. Chen MD PhD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2016 Annual Meeting

    Introduction: There are two published prognostic scales for brain metastasis (BM) patients undergoing radiosurgery that take into consideration the volume of the tumor treated. The score index for radiosurgery (SIR) inputs the largest tumor volume treated as a survival predictor while the cumulative intracranial tumor volume (CITV) inputs the total cumulative volume of the tumors treated. It remains unclear whether one scale is superior in terms of predicting survival.

    Methods: We compared the sensitivity and specificity of SIR and CITV scales in predicting one year survival using standard measures of continuous Net Reclassification Index (NRI>0) and Integrated Discrimination Improvement (IDI). The analysis was performed in two independent cohorts: 3020 BM patients treated at either the University of California San Diego (UCSD) or the Katsuta Hospital Mito Gamma House (KHMGH), and a second cohort of 3040 patients treated at Chiba/Tsukiji (CT) hospital.

    Results: In both cohorts, models incorporating age, karnofsky performance score, presence of extracranial disease, number of metastases and CITV performed better than models where CITV was replaced with the largest tumor volume. In the first cohort, models incorporating CITV showed a Net Reclassification Index (NRI>0) improvement 0.2416 (95% CI 0.1637 - 0.3194) and Integrated Discrimination Improvement (IDI) of 0.0029 (95% CI 0.0001 - 0.0064) relative to models incorporating the largest lesion size. Similar results were observed in the second cohort (NRI>0 of 0.2431 (95% CI 0.1692 - 0.3171) and IDI of 0.0068 (95% CI 0.0003 - 0.0011)).

    Conclusions: In both cohorts, models incorporating age, karnofsky performance score, presence of extracranial disease, number of metastases and CITV performed better than models where CITV was replaced with the largest tumor volume. In the first cohort, models incorporating CITV showed a Net Reclassification Index (NRI>0) improvement 0.2416 (95% CI 0.1637 - 0.3194) and Integrated Discrimination Improvement (IDI) of 0.0029 (95% CI 0.0001 - 0.0064) relative to models incorporating the largest lesion size. Similar results were observed in the second cohort (NRI>0 of 0.2431 (95% CI 0.1692 - 0.3171) and IDI of 0.0068 (95% CI 0.0003 - 0.0011)).

    Patient Care: Demonstrating the superiority of CITV over SIR will allow clinicians to use the model to better predict survival in these patients.

    Learning Objectives: CITV outperforms SIR model as a prognostic scale for brain metastasis patients undergoing SRS.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy